CELLector device to remove CD5/CD8 T-lymphocytes from donor bone marrow: Began Phase III trial

Applied Immune Sciences Inc. (AISX), Santa Clara, Calif. Product: CELLector device to remove CD5/ CD8 T-lymphocytes from donor bone marrow Indication: Prevent graft-versus-host disease in allogeneic m...